The ELISA Test Market's growth is driven by rising infectious and chronic diseases, enhancing demand for accurate diagnostics. Opportunities lie in technological advancements, like point-of-care ...
Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...
Citi Annual Global Healthcare Conference 2025 December 3, 2025 1:00 PM ESTCompany ParticipantsJoseph Busky - Chief ...
Immunoprecipitation Market OverviewThe global immunoprecipitation (IP) market is projected to witness a CAGR of 6-8% from 2024 to 2029. Growth in this market is largely driven by the rising focus on ...
Merakris Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative biologic drug therapies for chronic wounds, announced that it has successfully completed a Type C ...
b) Gold mineralization was extended up to 50 meters West , potentially increasing the number of defined ounces per vertical ...
We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will ...
NEW YORK, NY / ACCESS Newswire / December 1, 2025 / The global economy spent the past decade upgrading everything except the ...
Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / ...
As reported on November 4, 2025, three holes (PML-25-021, 026a, 030) were drilled below the depth resolution of the recent ...
Within its broader portfolio, four properties will be the focus for 2026, each hosting mineral occurrences of rare earth elements and niobium within pegmatites and syenites, with historic highlight ...
Citi Annual Global Healthcare Conference 2025 December 2, 2025 9:00 AM ESTCompany ParticipantsPrahlad Singh - CEO, President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results